Oracle Investment Management Inc Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Oracle Investment Management Inc

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $1.98 Million - $2.78 Million	-20,000 Reduced 20.0%	80,000 $2.17 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $2.08 Million - $3.13 Million	31,900 Added 46.84%	100,000 $400,000
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $295,200 - $389,750	5,000 Added 7.92%	68,100 $423,000
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $1.07 Million - $2.74 Million	-36,900 Reduced 36.9%	63,100 $2.49 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $13.6 Million - $28.4 Million	-496,000 Reduced 83.22%	100,000 $218,000
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $5.13 Million - $6.79 Million	137,200 Added 29.9%	596,000 $966,000
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $11.1 Million - $18.8 Million	-280,200 Reduced 37.92%	458,800 $692,000
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $25.5 Million - $39.4 Million	739,000 New	739,000 $3.42 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.